The clinical utility of the HFA-ICOS risk proforma for predicting heart failure hospitalization in a real-world cohort of multiple myeloma patients.

BMC Cardiovasc Disord · 2026 · PMC13255510 · PMID 42035004

Europe PMC DOI

hedged sentence

0.0840

closest p · 1.7× alpha

0.0840

boldest claim

The sentences

showed a trendp = 0.084so close (0.05 < p ≤ 0.1)

Additionally, CV mortality showed a trend of increase across risk groups (Fig. 3 B, log-rank p = 0.084), with 3-year cumulative incidences of 1.4% in the low-risk group, 5.1% in the medium-risk group, and 11.8% in the combined-high-risk group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.